Background illustration for clinical trials search

Stem Cells Clinical Trials

Find clinical trials for stem cells. Search for stem cells clinical trials in different cities and states across the United States.

Filter
New

Prophylactic DLI-X for Leukemia Relapse After HCT

for
Acute Lymphoid Leukemia, Acute Myeloid Leukemia,
Location: Tucson AZ
Sponsor: University of Arizona

Sex: All

Age: 0 - 65

Code: NCT07254793

Phase 1, Recruiting

BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

for
Advanced Solid Tumor, TNBC - Triple-Negative Breast Cancer,
Location: New Haven CT, New York NY, The Bronx NY,
Sponsor: SillaJen, Inc.

Sex: All

Age: 18+

Code: NCT05768932

Phase 1, Recruiting

Origin Stem and Logical Cup Post Market Clinical Follow-up

for
Hip Disease
Location: Cleveland OH
Sponsor: Signature Orthopaedics

Sex: All

Age: 18 - 70+

Code: NCT04123600

Recruiting

Vyxeos Plus Gilteritinib in Relapsed or Refractory, FLT3-Mutated AML

for
Acute Myeloid Leukemia With FLT3/ITD Mutation
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 18+

Code: NCT05024552

Phase 1, Recruiting

Left Bundle Branch Area Mapping for Conduction System Pacing

for
Left Bundle-Branch Block, Pacemaker DDD
Location: Boston MA
Sponsor: Steward St. Elizabeth's Medical Center of Boston, Inc.

Sex: All

Age: 18 - 70+

Code: NCT05884359

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Perform Humeral System Study

for
Osteoarthritis Shoulder, Avascular Necrosis,
Location: Columbus OH, Lexington KY, Eagan MN, Sioux Falls SD,
Sponsor: Stryker Trauma and Extremities

Sex: All

Age: 18+

Code: NCT05067543

Recruiting

GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) & Spinal Diffuse Midline Glioma(DMG)

for
Glioma of Spinal Cord, Glioma of Brainstem
Location: Stanford CA
Sponsor: Stanford University

Sex: All

Age: 2 - 60

Code: NCT04196413

Phase 1, Recruiting

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

for
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia,
Location: New York NY, Philadelphia PA, Durham NC, Toronto,
Sponsor: Syndax Pharmaceuticals

Sex: All

Age: 0+

Code: NCT04065399

Phase 1, Phase 2, Recruiting

Clinical Monitoring Strategy Versus Electrophysiology-guided Algorithmic Approach With a New LBBB After TAVI

for
Left Bundle-Branch Block, Aortic Valve Stenosis
Location: Halifax, Sherbrooke, Montreal, Ottawa, Hamilton, London,
Sponsor: Montreal Heart Institute

Sex: All

Age: 18+

Code: NCT03303612

Recruiting

Spartan Stem, World Cup and World Liner Post Market Clinical Follow-up Study

for
Hip Replacement
Location: Cleveland OH
Sponsor: Signature Orthopaedics

Sex: All

Age: 18 - 70+

Code: NCT06172569

Recruiting

Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms

for
Acute Biphenotypic Leukemia, Acute Myeloid Leukemia,
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT04797767

Phase 1, Phase 2, Recruiting

Everglade Stem, World Cup and World Liner Post Market Clinical Follow-up

for
Hip Disease
Location: Cleveland OH
Sponsor: Signature Orthopaedics

Sex: All

Age: 18 - 70+

Code: NCT06153940

Recruiting

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

for
Refractory Acute Myeloid Leukemia,
Location: New York NY, Philadelphia PA, Atlanta GA, Cincinnati OH,
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 1 - 30

Code: NCT06177067

Phase 1, Recruiting

Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma

for
Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma,
Location: Charlotte NC, Memphis TN, Baton Rouge LA, Tulsa OK,
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 1 - 18

Code: NCT06289673

Phase 4, Recruiting

SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia and Concurrent MLL-Rearrangement or NPM1 Mutation

for
Acute Myeloid Leukemia With FLT3/ITD Mutation,
Location: Philadelphia PA, Chapel Hill NC, Columbus OH,
Sponsor: Uma Borate

Sex: All

Age: 18+

Code: NCT06222580

Phase 1, Recruiting

Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)

for
Acute Myeloid Leukemia, Acute Lymphoid Leukemia,
Location: Gainesville FL
Sponsor: University of Florida

Sex: All

Age: 0 - 50

Code: NCT05322850

Phase 1, Phase 2, Recruiting

Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).

for
Diffuse Intrinsic Pontine Glioma, DIPG, Brain Tumor, CNS Tumor,
Location: Philadelphia PA, Atlanta GA, Chicago IL, Seattle WA
Sponsor: BrainChild Bio, Inc

Sex: All

Age: 1 - 26

Code: NCT07680439

Phase 2, Recruiting

Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT

for
Acute Myeloid Leukemia, Acute Lymphoid Leukemia,
Location: Palo Alto CA
Sponsor: Stanford University

Sex: All

Age: 18 - 70

Code: NCT06551584

Phase 1, Recruiting

Comparing Collared and Collarless Femoral Stems in Primary Total Hip Arthroplasty

for
Primary Total Hip Arthroplasty
Location: Washington D.C. DC
Sponsor: Medstar Health Research Institute

Sex: All

Age: 18 - 70+

Code: NCT07337642

Recruiting

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

for
Leukemia, Myeloid, Acute, Myelodysplastic Syndromes,
Location: New York NY, Hackensack NJ, Tampa FL, Nashville TN,
Sponsor: Orca Biosystems, Inc.

Sex: All

Age: 18+

Code: NCT07216443

Phase 2, Recruiting

What stem cell therapy clinical trials are studying now

Transplants for blood cancers and blood disorders. Hematopoietic stem cell transplant replaces a person's blood forming system with their own stored cells or a donor's. Trials test safer conditioning, better donor matching, including half matched family donors for sickle cell disease, and ways to prevent graft versus host disease.

Transplants for autoimmune disease. Resetting the immune system with a person's own stem cells is being tested against the best available drugs in relapsing multiple sclerosis, in a Phase 3 trial funded by the National Institutes of Health at more than 20 US sites.

Mesenchymal stromal cells. Cells from bone marrow or fat that calm inflammation, tested for Crohn's disease, graft versus host disease, and hard to heal wounds. The first one was approved in 2024 after decades of trials.

Cells made from stem cells. Lab grown dopamine neurons for Parkinson's disease and insulin producing islet cells for type 1 diabetes, both now in or entering late stage trials.

Gene corrected stem cells. A person's own blood stem cells are edited to fix a mutation and returned. Two such therapies for sickle cell disease were approved in 2023; see gene therapy clinical trials. Immune cell therapies such as CAR T are a different technology, covered on our CAR T cell therapy page.

Stem cell transplants are part of care for leukemia, lymphoma, and multiple myeloma; each page lists its own studies.

Article preview image

New to research? Read how informed consent works.

Informed Consent in Clinical Trials: What Is It and How It’s Obtained

Who can participate in stem cell therapy clinical trials?

Is stem cell therapy safe?

How long does stem cell therapy last?

Do stem cell trial participants get paid?

How to enroll in a stem cell clinical trial